A closely watched bill that aimed to regulate pharmacy benefit managers, or PBMs, failed to make it through the Senate. But ...

With over 70 per cent of its medicines imported and porous borders that are difficult to police, Nigeria has become a fertile ground for fake drugs, often hidden in plain sight on street corners, in ...

The feud is heating up between the state and big pharmacy chains like CVS as Governor Jeff Landry unofficially calls for a ...

The End Prescription Drug Ads Now Act aims to eliminate direct-to-consumer drug advertising across all media platforms, ...

The Japanese retailer of small goods, household items, stationery, snacks, and more will be the first location in Modesto.

The new law imposes restrictions and regulations on pharmacy benefit managers, or PBMs, that negotiate prescription drug prices between manufacturers, health insurance companies and pharmacies.

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

Federal agencies have scheduled a series of three web-based "listening sessions" to hear from commenters about issues that might be limiting competition in the U.S. prescription drug market and ...

AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.

UroGen Pharma's FDA nod for UGN-102 fuels recovery, but cash burn raises financing risks. Check out why I am maintaining my ...

ALEXANDRIA, VA / ACCESS Newswire / June 13, 2025 / The American Society of Consultant Pharmacists (ASCP) and the National Community Pharmacists Association (NCPA) have announced joint recommendations ...